Most ETF names tell you what they own. COWG tells you what it believes in. Pacer US Large Cap Cash Cows Growth Leaders ETF (NYSEARCA:COWG) screens for large-cap US companies generating strong projected free cash flows with above-average earnings growth, a methodology that sounds straightforward but produces a portfolio that looks nothing like the S&P 500.
What COWG Is Actually Built to Do
The fund’s core premise is that companies generating more cash than they spend are structurally healthier than those chasing growth at any cost. Pacer applies a rules-based screen targeting projected free cash flow yield and earnings growth, then builds a concentrated portfolio of the companies that pass. The result is a fund with $2.4 billion in assets, launched December 21, 2022, carrying a 0.49% expense ratio.
The portfolio leans heavily into two sectors. Information technology makes up 49.2% of holdings, with healthcare at 23.4%, together accounting for nearly three-quarters of the fund. Top positions include semiconductor equipment names like Lam Research (NASDAQ:LRCX | LRCX Price Prediction) and KLA Corp (NASDAQ:KLAC) alongside specialty pharma and biotech companies like Medpace Holdings (NASDAQ:MEDP) and Regeneron (NASDAQ:REGN). Financials have zero allocation.
The Performance Picture Is Mixed
The article title claims COWG is beating the S&P 500, but the data tells a more nuanced story. Over the past year, COWG returned 8% while SPY (NYSEARCA:SPY) returned 17.25% over the same period. That’s a meaningful gap. Where COWG does hold an edge recently is against the Nasdaq-100: COWG is up 0.26% year-to-date versus QQQ (NASDAQ:QQQ) down 1.14%, suggesting the cash flow screen has provided some cushion during the tech-heavy market softness of early 2026.
Since inception, COWG has returned roughly 79% from its December 2022 launch price. A 79% return over roughly three years outpaces inflation by a wide margin, though it still trails SPY over the same window.
The Tradeoffs Are Real
COWG’s cash flow screen doesn’t eliminate concentration risk. Nearly half the portfolio sits in technology, meaning a semiconductor downturn hits hard regardless of how strong free cash flow metrics look on paper. The fund’s portfolio turnover of 1.08 also signals active repositioning, which can create tax drag in taxable accounts. And at 0.38% dividend yield, income-seekers won’t find much here.
COWG’s design targets quality-growth exposure in tech and healthcare filtered through a profitability lens. The fund has trailed SPY over the past year by roughly 9 percentage points, and its 0.49% expense ratio adds cost compared to a basic S&P 500 index fund, without a demonstrated consistent return premium over that benchmark.
Top Gaining Stocks
Top Losing Stocks